ImExHS Limited (ASX:IME)
Australia · Delayed Price · Currency is AUD 0.3450
0.00 (0.00%)
Nov 9, 2026, 9:59 AM AEDT
ImExHS Market Cap
ImExHS has a market cap or net worth of 18.77 million as of November 6, 2026. It is the 39,766th most valuable company in the world and the 1,080th biggest in Australia. Its market cap has increased by 28.91% in one year.
Market Cap
18.77M
Enterprise Value
17.24M
Revenue
31.27M
Global Rank
Country Rank
#1,080 Australia
PE Ratio
99.65
ChartMarket Cap Chart
Since September 3, 2018, ImExHS's market cap has decreased from 24.99M to 18.77M, a decrease of -24.91%. That is a compound annual growth rate of -3.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 8, 2026 | 18.77M | -13.20% |
| Dec 30, 2025 | 21.62M | 25.63% |
| Dec 31, 2024 | 17.21M | -39.72% |
| Dec 29, 2023 | 28.55M | 50.42% |
| Dec 30, 2022 | 18.98M | -44.20% |
| Dec 31, 2021 | 34.01M | -28.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 599.55M |
| Healius | 363.08M |
| Monash IVF Group | 288.33M |
| Identifai Genetics | 78.71M |
| Cryosite | 59.55M |
| Microba Life Sciences | 25.91M |
| BCAL Diagnostics | 24.70M |
| Rhythm Biosciences | 24.42M |